Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility and Safety of IMP321 for Advanced Stage Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03252938
Recruitment Status : Completed
First Posted : August 17, 2017
Last Update Posted : May 21, 2021
Sponsor:
Information provided by (Responsible Party):
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 14, 2021
Actual Study Completion Date : April 14, 2021